$SHWZ
Medicine Man Technologies, Inc.

2024 Q1 Form 10-K Financial Statement

#000155837024004104 Filed on March 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $43.32M $172.4M
YoY Change 7.91% 8.2%
Cost Of Revenue $36.29M $96.42M
YoY Change 111.29% 29.69%
Gross Profit $7.034M $76.02M
YoY Change -69.38% -10.59%
Gross Profit Margin 16.23% 44.09%
Selling, General & Admin $21.47M $39.92M
YoY Change 22.96% 35.78%
% of Gross Profit 305.3% 52.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.230M $20.93M
YoY Change 94.95% 90.09%
% of Gross Profit 74.35% 27.54%
Operating Expenses $21.47M $72.73M
YoY Change 22.96% 0.78%
Operating Profit -$14.44M $3.289M
YoY Change -362.25% -74.42%
Interest Expense -$6.728M -$16.20M
YoY Change -59.26% 37.68%
% of Operating Profit -492.51%
Other Income/Expense, Net $68.40K -$18.10M
YoY Change 1728.88% 10.19%
Pretax Income -$24.87M -$14.81M
YoY Change 4.94% 314.86%
Income Tax $4.494M $19.74M
% Of Pretax Income
Net Earnings -$31.59M -$34.55M
YoY Change 5.83% 87.08%
Net Earnings / Revenue -72.91% -20.03%
Basic Earnings Per Share -$0.66
Diluted Earnings Per Share -$1.42 -$0.66
COMMON SHARES
Basic Shares Outstanding 77.44M 72.59M 64.54M
Diluted Shares Outstanding 64.54M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.71M $19.71M
YoY Change -49.99% -49.99%
Cash & Equivalents $19.25M $19.25M
Short-Term Investments $456.1K $456.1K
Other Short-Term Assets $3.914M $3.914M
YoY Change -26.06% -26.06%
Inventory $25.79M $25.79M
Prepaid Expenses
Receivables $4.261M $4.261M
Other Receivables $0.00 $0.00
Total Short-Term Assets $53.67M $53.67M
YoY Change -25.19% -25.19%
LONG-TERM ASSETS
Property, Plant & Equipment $31.11M $65.35M
YoY Change 14.86% 44.29%
Goodwill $67.50M
YoY Change -28.65%
Intangibles $166.2M
YoY Change 54.25%
Long-Term Investments $2.000M $2.000M
YoY Change 0.0% 0.0%
Other Assets $1.264M $3.462M
YoY Change -17.25% 126.71%
Total Long-Term Assets $304.5M $304.5M
YoY Change 21.23% 21.23%
TOTAL ASSETS
Total Short-Term Assets $53.67M $53.67M
Total Long-Term Assets $304.5M $304.5M
Total Assets $358.1M $358.1M
YoY Change 10.92% 10.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.34M $13.34M
YoY Change 69.99% 69.5%
Accrued Expenses $7.775M $9.797M
YoY Change -24.63% 21.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.547M $3.547M
YoY Change 57.64% 57.64%
Total Short-Term Liabilities $55.46M $55.46M
YoY Change 17.04% 17.04%
LONG-TERM LIABILITIES
Long-Term Debt $153.3M $153.3M
YoY Change 22.1% 22.1%
Other Long-Term Liabilities $30.13M $30.13M
YoY Change 74.04% 74.04%
Total Long-Term Liabilities $183.4M $183.4M
YoY Change 27.95% 28.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.46M $55.46M
Total Long-Term Liabilities $183.4M $183.4M
Total Liabilities $238.9M $238.9M
YoY Change 25.24% 25.24%
SHAREHOLDERS EQUITY
Retained Earnings -$80.79M
YoY Change 74.71%
Common Stock $74.89K
YoY Change 32.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.033M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $119.3M $119.3M
YoY Change
Total Liabilities & Shareholders Equity $358.1M $358.1M
YoY Change 10.92% 10.92%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$31.59M -$34.55M
YoY Change 5.83% 87.08%
Depreciation, Depletion And Amortization $5.230M $20.93M
YoY Change 94.95% 90.09%
Cash From Operating Activities $3.452M $12.20M
YoY Change -77.46% 7.44%
INVESTING ACTIVITIES
Capital Expenditures $1.149M $7.866M
YoY Change -50.09% -46.9%
Acquisitions
YoY Change
Other Investing Activities -$20.03K -$15.82M
YoY Change -100.07% -75.42%
Cash From Investing Activities -$1.169M -$26.44M
YoY Change -104.51% -66.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.659M -5.463M
YoY Change -93.52% -1549.53%
NET CHANGE
Cash From Operating Activities 3.452M 12.20M
Cash From Investing Activities -1.169M -26.44M
Cash From Financing Activities -2.659M -5.463M
Net Change In Cash -375.7K -19.70M
YoY Change -267.67% -70.79%
FREE CASH FLOW
Cash From Operating Activities $3.452M $12.20M
Capital Expenditures $1.149M $7.866M
Free Cash Flow $2.303M $4.335M
YoY Change -82.3% -225.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001622879
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Share Based Payment Arrangement Grantee Status Extensible List
ShareBasedPaymentArrangementGranteeStatusExtensibleList
http://fasb.org/us-gaap/2023#ShareBasedPaymentArrangementNonemployeeMember
CY2022 us-gaap Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List
FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55450
CY2023 dei Entity Registrant Name
EntityRegistrantName
MEDICINE MAN TECHNOLOGIES, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5289499
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
865 N. Albion Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80220
CY2023 dei City Area Code
CityAreaCode
(303)
CY2023 dei Local Phone Number
LocalPhoneNumber
371-0387
CY2023 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
62060000.00
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77438379
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19248932
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38949253
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4261159
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4471978
CY2023Q4 us-gaap Inventory Net
InventoryNet
25787793
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
11944
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1816
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
39270
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456099
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
454283
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3914064
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5293393
CY2023Q4 us-gaap Assets Current
AssetsCurrent
53668047
CY2022Q4 us-gaap Assets Current
AssetsCurrent
71735033
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8741782
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31113630
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
202111
CY2023Q4 us-gaap Goodwill
Goodwill
67499199
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32706765
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
166167877
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
107726718
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1263837
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1527256
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34233142
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18199399
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1996489
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
304476285
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
251147700
CY2023Q4 us-gaap Assets
Assets
358144332
CY2022Q4 us-gaap Assets
Assets
322882733
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13341561
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10723661
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7774691
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7462290
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
638020
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16508253
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4922724
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3139289
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3547011
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2250000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
25232782
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7297815
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55456789
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47381308
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
153262203
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30133452
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17314464
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
502070
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
183395655
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
143338054
CY2023Q4 us-gaap Liabilities
Liabilities
238852444
CY2022Q4 us-gaap Liabilities
Liabilities
190719362
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
85534
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
85534
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
86994
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
86
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74888392
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73968242
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
74888
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
56353
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202040968
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180381641
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80790927
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46241583
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
119291888
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
358144332
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
322882733
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172447786
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159379219
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
96424150
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
79090461
CY2023 us-gaap Gross Profit
GrossProfit
76023636
CY2022 us-gaap Gross Profit
GrossProfit
80288758
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39916518
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29036962
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
3558501
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
6722554
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1801740
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8011405
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
23883354
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
20990290
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
3574831
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2672713
CY2023 us-gaap Operating Expenses
OperatingExpenses
72734944
CY2022 us-gaap Operating Expenses
OperatingExpenses
67433924
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
3288692
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
12854834
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32069082
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-30139645
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
15870233
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
18414760
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68400
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24136
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-1968807
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-4684366
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1816
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-39270
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18097441
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16424385
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14808749
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3569551
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19740595
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14898064
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-34549344
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18467615
CY2023 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
8154993
CY2022 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7802809
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42704337
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26270424
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64535245
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53637003
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64535245
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53637003
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34549344
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18467615
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-34549344
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
17876320
CY2023 shwz Indemnification Of Escrowed Shares During Period Value Post Acquisitions Costs
IndemnificationOfEscrowedSharesDuringPeriodValuePostAcquisitionsCosts
49238
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
974093
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2023 shwz Restricted Stock Units Vested During Period Value
RestrictedStockUnitsVestedDuringPeriodValue
108978
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2985663
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
119291888
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
133569665
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18467615
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15737855
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1027288
CY2022 shwz Return Of Common Stock As Compensation To Employee Officers And Or Directors
ReturnOfCommonStockAsCompensationToEmployeeOfficersAndOrDirectors
-516091
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
812269
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023 us-gaap Profit Loss
ProfitLoss
-34549344
CY2022 us-gaap Profit Loss
ProfitLoss
-18467615
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20933541
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10660172
CY2023 shwz Non Cash Interest Expenses
NonCashInterestExpenses
4024604
CY2022 shwz Non Cash Interest Expenses
NonCashInterestExpenses
4118391
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1801740
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
8011405
CY2023 shwz Noncash Lease Expense
NoncashLeaseExpense
7648531
CY2022 shwz Noncash Lease Expense
NoncashLeaseExpense
3910679
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2090967
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-502070
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1968807
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4684369
CY2023 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
15870233
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
18414760
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1686049
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1686048
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8523493
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7484613
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
1816
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-39270
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3590473
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
812073
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-927259
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
105185
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4571069
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-789399
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1579349
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2770179
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-263419
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
248682
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7498128
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-13113041
CY2023 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-3241850
CY2022 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
11845245
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
17934967
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5270074
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12200963
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6694346
CY2023 us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
11944
CY2023 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
15834378
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
58981226
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7865654
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14007892
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2750000
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
2000000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26438088
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74989118
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-5354218
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-134498
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
978308
CY2023 shwz Proceeds From Payments For Statutory Withholdings On Restricted Stock Units
ProceedsFromPaymentsForStatutoryWithholdingsOnRestrictedStockUnits
-108978
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5463196
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
843810
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19700321
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-67450962
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38949253
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106400216
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19248932
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38949253
CY2023 us-gaap Interest Paid Net
InterestPaidNet
17896954
CY2022 us-gaap Interest Paid Net
InterestPaidNet
15243990
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12340000
CY2023 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
14006930
CY2022 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
14105320
CY2023 shwz Issuance Of Stock As Payment For Acquisitions
IssuanceOfStockAsPaymentForAcquisitions
18801192
CY2022 shwz Issuance Of Stock As Payment For Acquisitions
IssuanceOfStockAsPaymentForAcquisitions
15777373
CY2022 shwz Deferred Tax Liability From Acquisition
DeferredTaxLiabilityFromAcquisition
-3214080
CY2023 shwz Issuance Of Debt For Acquisition
IssuanceOfDebtForAcquisition
20157766
CY2022 shwz Issuance Of Debt For Acquisition
IssuanceOfDebtForAcquisition
17000000
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
55021859
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
34402043
CY2023 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
6267276
CY2022 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-1837221
CY2023 shwz Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
9046205
CY2022 shwz Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
62368339
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
297426
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
92940
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4261159
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4471978
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><i style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><i style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings and financial position. In accordance with ASC 230 <i style="font-style:italic;">Statement of Cash Flows,</i> the Company updated its 2022 statement of cash flows presentation to reflect cash proceeds from financing and the change in the derivative from the valuation date. This change had no impact on net earnings and financial position.</p>
CY2022Q4 us-gaap Investments
Investments
2000000.00
CY2023Q4 us-gaap Investments
Investments
2000000.00
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
202111
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19250000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38950000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
5180000
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6820000
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
2740000
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
1170000
CY2023Q4 shwz Prepaid Inventory Current And Noncurrent
PrepaidInventoryCurrentAndNoncurrent
1270000
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3880000
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
1530000
CY2022Q4 shwz Prepaid Inventory Current And Noncurrent
PrepaidInventoryCurrentAndNoncurrent
1410000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
13340000
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
10720000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7770000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7460000
CY2023Q4 shwz Loyalty Liability
LoyaltyLiability
1410000
CY2022Q4 shwz Loyalty Liability
LoyaltyLiability
1590000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2120000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2370000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2005306
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2325482
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5814290
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
14504490
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17968197
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5724210
CY2023Q4 us-gaap Inventory Net
InventoryNet
25787793
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
4268085
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
0
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39855412
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31989003
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8741782
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31113630
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023 us-gaap Depreciation
Depreciation
3841805
CY2022 us-gaap Depreciation
Depreciation
2911004
CY2023Q4 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
3000000.0
CY2023 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
52476845
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-32939892
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
181818767
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-16920270
CY2023Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
4780000
CY2022Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
6820000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1801740
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
9046205
CY2023 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-34350567
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1801740
CY2023Q4 us-gaap Goodwill
Goodwill
67499199
CY2021Q4 us-gaap Goodwill
Goodwill
43316267
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
62368339
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
640001
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
11719306
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
198874642
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32706765
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
124017580
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
16415903
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
8638112
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022 shwz Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag
true
CY2023 shwz Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag
true
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15124635
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14781757
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13970580
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13330407
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12492489
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
96468009
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
166167877
CY2023 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
15870232
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
18414760
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8523493
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7484613
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4917644
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6603695
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
32469683
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
40993176
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
156809214
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
127771520
CY2023Q4 shwz Less Current Portion Of Long Term Debt
LessCurrentPortionOfLongTermDebt
3547011
CY2022Q4 shwz Less Current Portion Of Long Term Debt
LessCurrentPortionOfLongTermDebt
2250000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
153262203
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3547011
CY2023Q4 shwz Long Term Debt Unamortized Debt Issuance Costs Year One
LongTermDebtUnamortizedDebtIssuanceCostsYearOne
1686049
CY2023Q4 shwz Long Term Debt Unamortized Debt Discount Year One
LongTermDebtUnamortizedDebtDiscountYearOne
9734935
CY2023Q4 shwz Total Long Term Debt Year One
TotalLongTermDebtYearOne
-7873973
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
42128139
CY2023Q4 shwz Long Term Debt Unamortized Debt Issuance Costs Year Two
LongTermDebtUnamortizedDebtIssuanceCostsYearTwo
1686049
CY2023Q4 shwz Long Term Debt Unamortized Debt Discount Year Two
LongTermDebtUnamortizedDebtDiscountYearTwo
11057799
CY2023Q4 shwz Total Long Term Debt Year Two
TotalLongTermDebtYearTwo
29384291
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
135634107
CY2023Q4 shwz Long Term Debt Unamortized Debt Issuance Costs Year Three
LongTermDebtUnamortizedDebtIssuanceCostsYearThree
1545546
CY2023Q4 shwz Long Term Debt Unamortized Debt Discount Year Three
LongTermDebtUnamortizedDebtDiscountYearThree
11676949
CY2023Q4 shwz Total Long Term Debt Year Three
TotalLongTermDebtYearThree
122411612
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
12887284
CY2023Q4 shwz Total Long Term Debt Year Four
TotalLongTermDebtYearFour
12887284
CY2023Q4 shwz Long Term Debt Maturities Repayments Of Principal
LongTermDebtMaturitiesRepaymentsOfPrincipal
194196541
CY2023Q4 shwz Long Term Debt Unamortized Debt Issuance Costs
LongTermDebtUnamortizedDebtIssuanceCosts
4917644
CY2023Q4 shwz Long Term Debt Unamortized Debt Discount
LongTermDebtUnamortizedDebtDiscount
32469683
CY2023Q4 shwz Total Long Term Debt
TotalLongTermDebt
156809214
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34233142
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4922724
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30133452
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8753538
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
7704717
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
6935556
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
5409672
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
4643953
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
21381630
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
54829065
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19772889
CY2023Q4 shwz Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
35056176
CY2023 shwz Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
85534
CY2023Q4 shwz Escrow Shares
EscrowShares
944
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q4 shwz Escrow Shares
EscrowShares
944
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023 us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
1000
CY2023Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1.20
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
8154993
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
7802809
CY2023Q3 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
500
CY2023Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
514512
CY2023Q4 shwz Conversion Of Preferred Stock Number Of Holders Converted
ConversionOfPreferredStockNumberOfHoldersConverted
2
CY2023Q4 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
480
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74888392
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73968242
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
219848
CY2023 shwz Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
2.05
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-34549344
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18467615
CY2023 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
8154993
CY2022 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7802809
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42704337
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26270424
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64535245
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53637003
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42704337
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26270424
CY2023 shwz Add Investor Note Accrued Interest
AddInvestorNoteAccruedInterest
1686051
CY2022 shwz Add Investor Note Accrued Interest
AddInvestorNoteAccruedInterest
4007557
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8523493
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7484613
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
15870233
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-18414760
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16624560
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33193014
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64535245
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53637003
CY2023 shwz Dilutive Effect Of Investor Notes
DilutiveEffectOfInvestorNotes
50603812
CY2022 shwz Dilutive Effect Of Investor Notes
DilutiveEffectOfInvestorNotes
49379715
CY2023 shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
115139056
CY2022 shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
103016719
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022 shwz Effective Income Tax Rate Reconciliation Deferred Tax True Up Amount
EffectiveIncomeTaxRateReconciliationDeferredTaxTrueUpAmount
1082735
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
203236
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19740595
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14898064
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1619741
CY2023Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
2744673
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
20745917
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
17127037
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1900829
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
483037
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22646746
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17610074
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-725879
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-611750
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2180272
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2100260
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2906151
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2712010
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15408802
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3569552
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3235848
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-749606
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1171514
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-949986
CY2023 shwz Effective Income Tax Rate Reconciliation Nondeductible Expense Expenses Under Irc Section280 E Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpensesUnderIrcSection280EAmount
19957552
CY2022 shwz Effective Income Tax Rate Reconciliation Nondeductible Expense Expenses Under Irc Section280 E Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpensesUnderIrcSection280EAmount
16308522
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
89286
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
177912
CY2023 shwz Effective Income Tax Rate Reconciliation Derivative Liability Remeasurement Amount
EffectiveIncomeTaxRateReconciliationDerivativeLiabilityRemeasurementAmount
-3332749
CY2022 shwz Effective Income Tax Rate Reconciliation Derivative Liability Remeasurement Amount
EffectiveIncomeTaxRateReconciliationDerivativeLiabilityRemeasurementAmount
-3867100
CY2023 shwz Effective Income Tax Rate Reconciliation Nondeductible Expense Penalties Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePenaltiesAmount
1796633
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
941328
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
244130
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2062697
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
17230
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-176568
CY2023 shwz Effective Income Tax Rate Reconciliation Return To Provision Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount
3416949
CY2022 shwz Effective Income Tax Rate Reconciliation Return To Provision Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount
4890722
CY2023 shwz Effective Income Tax Rate Reconciliation Deferred Tax True Up Amount
EffectiveIncomeTaxRateReconciliationDeferredTaxTrueUpAmount
1058492
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1129939
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2573017
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2359197
CY2023Q4 shwz Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
3275084
CY2022Q4 shwz Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1705867
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
219966
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
598861
CY2023Q4 shwz Deferred Tax Assets Loyalty Points
DeferredTaxAssetsLoyaltyPoints
365565
CY2022Q4 shwz Deferred Tax Assets Loyalty Points
DeferredTaxAssetsLoyaltyPoints
412218
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
235839
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
367776
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
114269
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
217320
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
26953
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
36742
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
48600
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
8537
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11223707
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6836457
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
5902988
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
5594714
CY2023Q4 shwz Deferred Tax Liabilities Operating Leases Amount
DeferredTaxLiabilitiesOperatingLeasesAmount
3206284
CY2022Q4 shwz Deferred Tax Liabilities Operating Leases Amount
DeferredTaxLiabilitiesOperatingLeasesAmount
1595394
CY2023Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
117946
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
117750
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
30669
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
9227218
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7338527
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1996489
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
502070
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2062697
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-004104-index-headers.html Edgar Link pending
0001558370-24-004104-index.html Edgar Link pending
0001558370-24-004104.txt Edgar Link pending
0001558370-24-004104-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
shwz-20231231.xsd Edgar Link pending
shwz-20231231x10k.htm Edgar Link pending
shwz-20231231xex10d21.htm Edgar Link pending
shwz-20231231xex10d22.htm Edgar Link pending
shwz-20231231xex19d1.htm Edgar Link pending
shwz-20231231xex19d1001.jpg Edgar Link pending
shwz-20231231xex21d1.htm Edgar Link pending
shwz-20231231xex23d1.htm Edgar Link pending
shwz-20231231xex31d1.htm Edgar Link pending
shwz-20231231xex31d2.htm Edgar Link pending
shwz-20231231xex32d1.htm Edgar Link pending
shwz-20231231xex4d1.htm Edgar Link pending
shwz-20231231_def.xml Edgar Link unprocessable
shwz-20231231_pre.xml Edgar Link unprocessable
shwz-20231231x10k_htm.xml Edgar Link completed
shwz-20231231_cal.xml Edgar Link unprocessable
shwz-20231231_lab.xml Edgar Link unprocessable